Clincosm LogoSign in Get a demo

squamous cell carcinoma of esophagus

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

Not yet recruiting
  • Squamous Cell Carcinoma of Esophagus
    • (no location specified)
    Feb 25, 2023

    Squamous Cell Carcinoma of Esophagus Trial in Hong Kong (Andrographis Paniculata)

    Completed
    • Squamous Cell Carcinoma of Esophagus
    • Andrographis Paniculata
    • Hong Kong, Outside Of US & Canada, China
      Department of Surgery, Faculty of Medicine, The Chinese Universi
    Nov 5, 2021

    Squamous Cell Carcinoma of Esophagus Trial in France (FU-CDDP, LV5FU2-CDDP, FOLFOX)

    Terminated
    • Squamous Cell Carcinoma of Esophagus
    • Brest, France
    • +16 more
    May 14, 2019

    Squamous Cell Carcinoma of Esophagus Trial in Seoul (BIBW2992)

    Unknown status
    • Squamous Cell Carcinoma of Esophagus
    • Seoul, Korea, Republic of
      Severance hospital
    Feb 7, 2019

    Squamous Cell Carcinoma of Esophagus Trial in Hangzhou (nanoparticle albumin-bound paclitaxel)

    Withdrawn
    • Squamous Cell Carcinoma of Esophagus
    • nanoparticle albumin-bound paclitaxel
    • Hangzhou, Zhejiang, China
      The first affiliated hospital, Zhejiang University
    Mar 4, 2015

    Squamous Cell Carcinoma of Esophagus Trial in Zhejiang (Nimotuzumab)

    Withdrawn
    • Squamous Cell Carcinoma of Esophagus
    • Zhejiang, Zhejiang, China
      The first affiliated hospital, Zhejiang University
    Mar 4, 2015

    Adenocarcinoma of Esophagus, Squamous Cell Carcinoma of Esophagus Trial in Boston (drug, device, procedure)

    Completed
    • Adenocarcinoma of Esophagus
    • Squamous Cell Carcinoma of Esophagus
    • Boston, Massachusetts
    • +1 more
    Nov 7, 2014